Micropure Parenterals Pvt. Ltd. (MPPL) is a state-of the-art for Liquid Injectable facility for Liquid vials, Ampoules & PFS. Micropure journey has begun in the year of 1997, and we have been in the market over two decades. The Manufacturing sites of Unit-I and Unit-II are located 80 km north of Mumbai, Maharashtra in a pollution free area. The total site area is about 2.25 Sq. hectares with a built-up area of about 40,000 sq.ft. Adequate open space is provided between the buildings at site. We are in the ceaseless pursuit of versatile and sophisticated product range. 

The products manufactured by Micropure are exported to many of the countries, i.e., CIS, African Nations, South East Asia, and Latin America such as Uzbekistan, Turkmenistan, Tajikistan, Kazakhstan, Nigeria, Uganda, Kenya, Yemen, Cambodia, Ghana, Ivory Coast, Guatemala, Venezuela, El Salvador, Dominican Republic, and many other international markets.



The site has been inspected and approved by the regulatory authorities like, National Agency for Food and Drug Administration and control (NAFDA) Nigeria, Ministry of Health (MOH), Republic of Yemen, National Drug Authority (NDA) Uganda, CDSCO for WHO GMP certification and State FDA inspection etc.

Today Micropure is known as a renowned contract manufacturing company for leading pharmaceutical companies like, Cadila Pharmaceuticals, Alkem Laboratories, Aristo Pharmaceuticals, Caplin Point Laboratories, Wockhardt Limited, Mapra Laboratories Pvt ltd. for both domestic and export markets.

The MPPL has been collaborated with ‘Favnox Pharmaceuticals Pvt. Ltd.’ by providing the legal rights to expand the business globally.

The MPPL has set a regulatory experienced team for each and individual department and the Manufacturing capacity of MPPL is 60.5 Million vials per annum, 60 Million Ampoules per annum and 15 Million PFS per annum. MPPL strongly believes in robust processes to manufacture products of predefined standards. The management of MPPL understands the importance of strict adherence to QMS to deliver safe, effective, stable, and quality medicines to patients.




Umed Pharma Lab Pvt. Ltd. is established in June 2011. The work of Umed has been monitored from different locations like UK, Bangladesh and India. The Head office is located at Bachupally Village, Hyderabad. Umed is working with a vision of multi-disciplinary contribution services to regulatory and emerging Pharmaceuticals and Biological industries by providing Formulation Research & Development (FR&D), Analytical Testing Services, Microbiological Testing and Evolution, Calibration, Qualification & Validation Services. Umed having accreditations of FDA, NABL, ISO, QCI and DCA.


Umed is providing services for a leading Pharma Companies like Pfizer, Cipla, Aurobindo Pharma, Dr.Reddy’s, Sun Pharma, Abbott, Biocon, Mylan laboratories , Wokhardt, Bharath Biotech , Natco, Granules India etc.


Umed Pharma Lab Pvt. Ltd. has been collaborated with Favnox Pharmaceuticals Pvt. Ltd. to transform their Technologies, Facilities, Equipment, Documents and Scientists for Formulation Research & Development (FR&D), Analytical Research & Development (AR&D), Stability Studies etc., to innovate and develop the product strategies, exclusively for Injectable Products of Small Volume Parenteral (SVP) in a dosage form of Liquid Injectables, Lyophilized Products and Sterile Dry- Powders.